MedTrace Logo

Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial)

NCT01696994 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 78216

Last updated 2026-04-29

Study results available
· View outcomes & findings →

Summary

This clinical trial studies whether screening methods used to diagnose cancer of the prostate, lung, colon, rectum, or ovaries can reduce deaths from these cancers. Screening tests may help doctors find cancer cells early and plan better treatment for ovarian cancer. The ovarian cancer screening tests are part of a trial that addresses the screening of four cancer sites, each with their own results record: prostate (NCT00002540), lung (NCT01696968), colorectal (NCT01696981), and ovarian (NCT01696994).

Conditions

  • Ovarian Carcinoma
  • Ovarian Germ Cell Tumor

Interventions

OTHER

Laboratory Biomarker Analysis

Correlative studies

OTHER

Screening Questionnaire Administration

Undergo questionnaire assessments

PROCEDURE

Ultrasound Imaging

Undergo TVU

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    lead NIH

Principal Investigators

  • Christine D Berg · National Cancer Institute (NCI)

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
55 Years
Max Age
74 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
1993-11-16
Primary Completion
2012-05-21
Completion
2027-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01696994 on ClinicalTrials.gov